Ansell: Interim result 2015
Global condom and glove maker Ansell has reported a 34% jump in net profit, but its share price offers little protection.
OzForex CEO resigns
OzForex has become a bit accident-prone, after the loss of a banking partner and now its CEO, and we're downgrading to Hold.
NAB: Q1 Result 2015
National Australia Bank has announced its first quarter result, but we're closer to selling than buying.
REA Group: Interim result 2015
For its lucky shareholders (including News Corp), REA Group is the gift that keeps on giving and its latest result - the first from its new CEO - duly delivered.
Echo: Interim result 2015
Investments in its trophy property The Star continue to bear fruit, but Echo's expensive share price and high risks keep it a Sell.
Time to Sell Platinum
The lower Aussie dollar will no doubt benefit this international fund manager, but the current price takes account of that and more.
Ideas Lab: Karoon Gas
Buying a dollar for fifty cents is the aim of every investor. Karoon Gas offers the chance to almost do that.
Time to Sell Platinum
The lower Aussie dollar will no doubt benefit this international fund manager, but the current price takes account of that and more.
Credit Corp: Interim result 2015
Debt collector Credit Corp has reported another decent result but, while direct lending beat expectations, the US division lagged.
LifeHealthcare: retail therapy
This medical products distributor enjoys some of the same tailwinds as the healthcare sector and, what's more, it's going cheap. But looks can be deceiving.
Biting into BHP Billiton: Pt 2
BHP is exposed to the cycle but isn't a slave to it. Here, we examine how profits and cash flow for the business will change as commodity prices adjust lower.
Treasury downgraded to Sell and Cease Coverage
This investor in fund managers is an even more complex company since last year's merger with Northern Lights, and with the price around our Sell target, we recommend you Sell.
Flight Centre's split ticket
Flight Centre's corporate travel business is performing well, but its fortunes rest on how much the internet encroaches on its retail business.
SomnoMed's record quarter
Strong performances in the US and Europe have underpinned a record quarter for this maker of mandibular splints - and it looks like there's more to come.
Flight Centre's split ticket
Flight Centre's corporate travel business is performing well, but its fortunes rest on how much the internet encroaches on its retail business.
Bradken's broken takeover
A potential takeover for Bradken has fallen away. The company must traverse the wreckage that is mining services alone.
Auckland Airport downgraded to Sell
Auckland Airport stands to benefit from the low oil price, but its share price already has done.
Biting into BHP Billiton: Pt 1
Amid falling iron ore and oil prices, we're upgrading BHP to a buy. Here, we explain why.
Biting into BHP Billiton
Amid falling iron ore and oil prices, we're upgrading BHP to buy. Here we explain why.
ResMed: Interim result 2015
New products have driven an excellent first-half performance for this quality healthcare company.
Austbrokers profit downgrade
Austbrokers has announced a profit downgrade, but our long term view hasn't changed.
The Reject Shop shows signs of life
It's been a rough year for The Reject Shop, but things are moving in the right direction.
ResMed hits its straps
New products have driven an excellent first-half result for this quality healthcare company.
Perpetual reports Q2 net inflow
Another net inflow of funds for this high-quality fund manager bodes well for its forthcoming interim result.
Northern Star fires up
Northern Star's share price has doubled in less than two months. Gaurav Sodhi explains why and suggests what to do now.
Call 1300 880 160
Start a chat
Schedule a call
